Login / Signup
A repair pathway lost in multiple sclerosis provides a new drug opportunity.
Lise Torp Jensen
Kathrine E Attfield
Lars Fugger
Published in:
Nature immunology (2024)
Keyphrases
</>
multiple sclerosis
white matter
adverse drug